{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:54:21Z","timestamp":1768283661744,"version":"3.49.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>High mobility group box 1 (HMGB1) is a kind of proinflammatory mediator that acts as an alarmin when released by dying, injured or activated cells. Previous studies have reported that HMGB1 are closely linked to antineutrophil cytoplasmic antibody-associated vasculitis (AAV). The present study aimed to evaluate whether serum HMGB1 levels were associated with systemic vasculitis (VAs).<\/jats:p>\n            <jats:p>The study population consisted of 51 patients with VAs, 46 patients with essential hypertension (EH) and 46 healthy controls (HC). Thirty-five patients with VAs had in active stage and 16 patients with VAs in an inactive stage. Furthermore, 31 patients with VAs had renal involvement, the other 20 patients were selected for without renal involvement. Serum HMGB1 levels were measured by enzyme-linked immunosorbent assay. Associations between serum HMGB1 levels with clinical and laboratory parameters were analyzed.<\/jats:p>\n            <jats:p>Serum HMGB1 levels in patients with VAs were significantly higher than in EH and HC (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05), and no difference regarding serum HMGB1 levels could be found between EH and HC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.208). Serum HMGB1 levels in VAs patients with active stage were significantly higher than those in HC and VAs patients with inactive stage (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Patients with renal involvement and non-renal involvement had increased HMGB1 levels compared with HC (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). In addition, serum HMGB1 levels were significantly higher in patients with renal involvement compared with non-renal involvement patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001). Correlation analysis showed that serum HMGB1 levels were positive significant correlated with the Birmingham Vasculitis Activity Score, hypersensitive C reactive protein (Hs-CRP), serum creatinine (Scr) and 24-hour proteinuria (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Among the subsets of VAs, serum HMGB1 levels were significantly higher in AAV, polyarteritis nodosa (PAN) and takayasu arteritis (TA) than in HC (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). More interestingly, serum HMGB1 were significantly higher in patients with PAN compared with AAV and TA patients (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). Furthermore, there was positive correlation between serum HMGB1 levels and Hs-CRP, Scr, and 24-hour proteinuria in patients with PAN (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05).<\/jats:p>\n            <jats:p>Serum HMGB1 levels are increased in patients with VAs compared with HC and EH and can reflect the disease activity and renal involvement.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014493","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T08:56:52Z","timestamp":1549529812000},"page":"e14493","source":"Crossref","is-referenced-by-count":7,"title":["Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis"],"prefix":"10.1097","volume":"98","author":[{"given":"Bin","family":"Zhu","sequence":"first","affiliation":[{"name":"Xinjiang Medical University"},{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[{"name":"Xinjiang Medical University"},{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulalibieke","family":"Heizati","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Yao","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Hong","sequence":"additional","affiliation":[{"name":"Center for Hypertension of People's Hospital of Xinjiang Uygur Autonomous Region, Hypertension Institute of Xinjiang, Urumqi, Xinjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","first-page":"12","article-title":"One year in review 2018: systemic vasculitis","volume":"36 Suppl 111","author":"Elefante","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20230914","first-page":"40","article-title":"Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study","volume":"35 Suppl 103","author":"Benarous","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"(4 Suppl 73)","key":"R3-20230914","first-page":"S154","article-title":"Systemic vasculitis: how little we know about their societal and economic burden","volume":"30","author":"Trieste","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"(3 Suppl 97)","key":"R4-20230914","first-page":"S111","article-title":"Assessment of work limitations and disability in systemic vasculitis","volume":"34","author":"Barra","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-015-0497-0","article-title":"New insights on biomarkers in systemic vasculitis","volume":"17","author":"Perez-Alamino","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cyto.2018.06.031","article-title":"Exercise alarms the immune system: a HMGB1 perspective","volume":"110","author":"Goh","year":"2018","journal-title":"Cytokine"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1189\/jlb.1212662","article-title":"The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis","volume":"93","author":"Yang","year":"2013","journal-title":"J Leukoc Biol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/rheumatology\/ket134","article-title":"The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis","volume":"52","author":"Chen","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"4570715","DOI":"10.1155\/2017\/4570715","article-title":"Elevated serum level of HMGB1 in patients with the antiphospholipid syndrome","volume":"2017","author":"Manganelli","year":"2017","journal-title":"J Immunol Res"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/ar3332","article-title":"High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus","volume":"13","author":"Abdulahad","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"e11531","DOI":"10.1097\/MD.0000000000011531","article-title":"Association of serum\/plasma high mobility group box 1 with autoimmune diseases: a systematic review and meta-analysis","volume":"97","author":"Zhu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/03009740802144143","article-title":"High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease","volume":"37","author":"Hoshina","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1136\/ard.2010.146456","article-title":"Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's)","volume":"70","author":"Henes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/acr.22187","article-title":"Association of circulating level of high mobility group box 1 with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis","volume":"65","author":"Wang","year":"2013","journal-title":"Arthritis Care Res"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"e96067","DOI":"10.1371\/journal.pone.0096067","article-title":"Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis","volume":"9","author":"Souza","year":"2014","journal-title":"PLoS One"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar4284","article-title":"Is serum HMGB1 a biomarker in ANCA-associated vasculitis?","volume":"15","author":"de Souza","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13075-015-0672-8","article-title":"High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins","volume":"17","author":"de Souza","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R25-20230914","article-title":"Compared performance of Spot and SW800 photoscreeners on Chinese children","author":"Qian","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.immuni.2018.09.021","article-title":"HMGB1: LPS delivery vehicle for caspase-11-mediated pyroptosis","volume":"49","author":"Kim","year":"2018","journal-title":"Immunity"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.autrev.2015.07.010","article-title":"Emerging role of high mobility group box 1 in ANCA-associated vasculitis","volume":"14","author":"Wang","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2796.2011.02432.x","article-title":"High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus","volume":"270","author":"Urbonaviciute","year":"2011","journal-title":"J Intern Med"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"e0123586","DOI":"10.1371\/journal.pone.0123586","article-title":"Urinary levels of high mobility group box-1 are associated with disease activity in anti-neutrophil cytoplasmic autoantibody-associated vasculitis","volume":"10","author":"Ma","year":"2015","journal-title":"PLoS One"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/jcmm.13065","article-title":"HMGB1 contributes to glomerular endothelial cell injury in ANCA-associated vasculitis through enhancing endothelium-neutrophil interactions","volume":"21","author":"Wang","year":"2017","journal-title":"J Cell Mol Med"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2119\/molmed.2010.00132","article-title":"High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations","volume":"17","author":"Bruchfeld","year":"2011","journal-title":"Mol Med"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.smim.2018.02.011","article-title":"High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells","volume":"38","author":"Andersson","year":"2018","journal-title":"Semin Immunol"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13075-015-0903-z","article-title":"High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation","volume":"18","author":"Ma","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13075-015-0587-4","article-title":"High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and toll-like receptor 4","volume":"17","author":"Wang","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.lpm.2017.05.034","article-title":"Epidemiology of Takayasu arteritis","volume":"46","author":"Onen","year":"2017","journal-title":"Presse Med"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fped.2018.00265","article-title":"Takayasu Arteritis","volume":"6","author":"Russo","year":"2018","journal-title":"Front Pediatr"},{"key":"R37-20230914","first-page":"135","article-title":"Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda","volume":"36 Suppl 111","author":"Karadag","year":"2018","journal-title":"Clin Exp Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902080-00103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:10:14Z","timestamp":1694722214000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902080-00103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014493","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}